1,284
Views
12
CrossRef citations to date
0
Altmetric
Research Article

A higher aspect ratio enhanced bioaccumulation and altered immune responses due to intravenously-injected aluminum oxide nanoparticles

, , , , , , , , & show all
Pages 439-448 | Received 28 Jul 2015, Accepted 16 Nov 2015, Published online: 04 Apr 2016

References

  • Amanzada A, Moriconi F, Mansuroglu T, Cameron S, Ramadori G, Malik IA. 2014. Induction of chemokines and cytokines before neutrophils and macrophage recruitment in different regions of rat liver after TAA administration. Lab Invest. 94:235–247.
  • Bal W, Sokolowska M, Kurowska E, Faller P. 2013. Binding of transition metal ions to albumin: Sites, affinities and rates. Biochim Biophys Acta. 1830:5444–5455.
  • Ban M, Langonné I, Huguet N, Guichard Y, Goutet M. 2013. Iron oxide particles modulate the ovalbumin-induced TH2 immune response in mice. Toxicol Lett. 216:31–39.
  • Baud L, Ardaillou R. 1993. Involvement of reactive oxygen species in kidney damage. Br Med Bull. 49:621–629.
  • Borgognoni CF, Mormann M, Qu Y, Schäfer M, Langer K, Öztürk C, Wagner S, Chen C, Zhao Y, Fuchs H, et al. 2015. Reaction of human macrophages on protein corona covered TiO2 nanoparticles. Nanomedicine. 11:275–282.
  • Borm PJ, Robbins D, Haubold S, Kuhlbusch T, Fissan H, Donaldson K, Schins R, Stone V, Kreyling W, Lademann J, et al. 2006. The potential risks of nanomaterials: A review carried out for ECETOC. Particle Fibre Toxicol. 3:11.
  • Braakhuis HM, Park MV, Gosens I, De Jong WH, Cassee FR. 2014. Physicochemical characteristics of nanomaterials that affect pulmonary inflammation. Particle Fibre Toxicol. 11:18.
  • Brzozowska A. 1989. Interaction of iron, zinc and copper in the body of animals and humans. Rocz Panstw Zakl Hig. 40:302–312.
  • Bruinink A, Wang J, Wick P. 2015. Effect of particle agglomeration in nanotoxicology. Arch Toxicol. 89:659–675.
  • Ceni E, Mello T, Galli A. 2014. Pathogenesis of alcoholic liver disease: Role of oxidative metabolism. World J Gastroenterol. 20:17756–17772.
  • Cheng LC, Jiang X, Wang J, Chen C, Liu RS. 2013. Nano-bio effects: Interaction of nanomaterials with cells. Nanoscale. 5:3547–3569.
  • Cho M, Cho WS, Choi M, Kim SJ, Han BS, Kim SH, Kim HO, Sheen YY, Jeong J. 2009. The impact of size on tissue distribution and elimination by single intravenous injection of silica nanoparticles. Toxicol Lett. 189:177–183.
  • Cyert MS, Philpott CC. 2013. Regulation of cation balance in Saccharomyces cerevisiae. Genetics. 193:677–713.
  • Di Gioacchino M, Petrarca C, Lazzarin F, Di Giampaolo L, Sabbioni E, Boscolo P, Mariani-Costantini R, Bernardini G. 2011. Immunotoxicity of nanoparticles. Intl J Immunopathol Pharmacol. 24:65S–71S.
  • Dykman L, Khlebtsov N. 2012. Gold nanoparticles in biomedical applications: Recent advances and perspectives. Chem Soc Rev. 41:2256–2282.
  • Enomoto N, Takei Y, Yamashina S, Ikejima K, Kitamura T, Sato N. 2007. Anti-inflammatory strategies in alcoholic steato-hepatitis. J. Gastroenterol Hepatol. 22 (Suppl 1):S59–61.
  • Feng D, Wang Y, Xu Y, Luo Q, Lan B, Xu L. 2009. IL-10 deficiency exacerbates halothane induced liver injury by increasing IL-8 expression and neutrophil infiltration. Biochem Pharmacol. 77:277–284.
  • Gaiser BK, Hirn S, Kermanizadeh A, Kanase N, Fytianos K, Wenk A, Haberl N, Brunelli A, Kreyling WG, Stone V. 2013. Effects of silver nanoparticles on the liver and hepatocytes in vitro. Toxicol Sci. 131:537–547.
  • Geraets L, Oomen AG, Krystek P, Jacobsen NR, Wallin H, Laurentie M, Verharen HW, Brandon EF, de Jong WH. 2014. Tissue distribution and elimination after oral and intravenous administration of different titanium dioxide nanoparticles in rats. Particle Fibre Toxicol. 11:30.
  • Ghanta SR, Muralidharan T. 2013. Chemical synthesis of aluminum nanoparticles. J Nanopart Res. 15:1715–1724.
  • Gomes M, Teixeira AL, Coelho A, Araújo A, Medeiros R. 2014. Role of inflammation in lung cancer. Adv Exp Med Biol. 816:1–23.
  • Hagens WI, Oomen AG, de Jong WH, Cassee FR, Sips AJ. 2007. What do we (need to) know about the kinetic properties of nanoparticles in the body? Regul Toxicol Pharmacol. 49:217–229.
  • Johnston H, Brown D, Kermanizadeh A, Gubbins E, Stone V. 2012. Investigating the relationship between nanomaterial hazard and physicochemical properties: Informing the exploitation of nanomaterials within the therapeutic and diagnostic applications. J Contr Rel. 164:307–313.
  • Junnila SK. 2015. Type 1 diabetes epidemic in Finland is triggered by zinc-containing amorphous silica nanoparticles. Med Hypotheses. 84:336–340.
  • Li N, Xia T, Nel AE. 2008. The role of oxidative stress in ambient particulate matter-induced lung diseases and its implications in the toxicity of engineered nanoparticles. Free Radic Biol Med. 44:1689–1699.
  • Li XB, Zheng H, Zhang ZR, Li M, Huang ZY, Schluesener HJ, Li YY, Xu SQet al. 2009. Glia activation induced by peripheral administration of aluminum oxide nanoparticles in rat brains. Nanomedicine. 5:473–479.
  • Li Y, Yu S, Wu Q, Tang M, Pu Y, Wang D. 2012. Chronic Al2O3-nanoparticle exposure causes neurotoxic effects on locomotion behaviors by inducing severe ROS production and disruption of ROS defense mechanisms in nematode. Caenorhabditis elegans. J Hazard Mater. 219:221–230.
  • Mangge H, Becker K, Fuchs D, Gostner JM. 2014. Anti-oxidants, inflammation, and cardiovascular disease. World J Cardiol. 6:462–477.
  • Moghimi SM, Hunter AC, Murray JC. 2005. Nanomedicine: Current status and future prospects. FASEB J. 19:311–330.
  • Mondal S, Haldar S, Saha P, Ghosh TK. 2010. Metabolism and tissue distribution of trace elements in broiler chickens’ fed diets containing deficient and plethoric levels of copper, manganese, and zinc. Biol Trace Elem Res. 137:190–205.
  • Morsy GM, Abou El-Ala KS, Ali AA. 2013a. Studies on fate and toxicity of nano-alumina in male albino rats: Oxidative stress in the brain, liver and kidney. Toxicol Ind Health. [Epub ahead of print]. DOI: 10.1177/0748233713498462.
  • Morsy GM, Abou El-Ala KS, Ali AA. 2013b. Studies on fate and toxicity of nano-alumina in male albino rats: Lethality, bioaccumulation and genotoxicity. Toxicol Ind Health. [Epub ahead of print]. DOI: 10.1177/0748233713498449.
  • Mukherjee D, Rai A, Zachariah MR. 2006. Quantitative laser-induced breakdown spec-troscopy for aerosols via internal calibration: Application to the oxidative coatings of aluminum nanoparticles. Aerosol Sci. 37:677–695.
  • Nel AE, Mädler L, Velegol D, Xia T, Hoek EM, Somasundaran P, Klaessig F, Castranova V, Thompson M. 2009. Understanding biophysico-chemical interactions at the nano-bio interface. Nat Mater. 8:543–557.
  • Oberdörster G, Oberdörster E, Oberdörster J. 2005. Nanotoxicology: An emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect. 113:823–839.
  • Oesterling E, Chopra N, Gavalas V, Arzuaga X, Lim EJ, Sultana R, Butterfield DA, Bachas L, Hennig B. 2008. Alumina nanoparticles induce expression of endothelial cell adhesion molecules. Toxicol Lett. 178:160–166.
  • Palomäki J, Karisola P, Pylkkänen L, Savolainen K, Alenius H. 2010. Engineered nano-materials cause cytotoxicity and activation on mouse antigen-presenting cells. Toxicology. 267:125–131.
  • Park EJ, Lee GH, Shim HW, Kim JH, Cho MH, Kim DW. 2014. Comparison of toxicity of different nanorod-type TiO2 polymorphs in vivo and in vitro. J Appl Toxicol. 34:357–366.
  • Park EJ, Lee GH, Shim JH, Cho MH, Lee BS, Kim YB, Kim JH, Kim Y, Kim DW. 2015. Comparison of the toxicity of aluminum oxide nanorods with different aspect ratio. Arch. Toxicol. 88:1771–1782.
  • Park EJ, Shim JH, Kim Y, Han BS, Yoon C, Lee S, Cho MH, Lee BS, Kim JH. 2015. A 13-week repeated dose oral toxicity and bioaccumulation of aluminum oxide nanoparticles in mice. Arch Toxicol. 89:371–379.
  • Petrarca C, Perrone A, Verna N, Verginelli F, Ponti J, Sabbioni E, Di Giampaolo L, Dadorante V, Schiavone C, Boscolo P, et al. 2006. Cobalt nano-particles modulate cytokine in vitro release by human mononuclear cells mimicking autoimmune disease. Intl J Immunopathol Pharmacol. 19(Suppl 4):11–14.
  • Petrasek J, Bala S, Csak T, Lippai D, Kodys K, Menashy V, Barrieau M, Min SY, Kurt-Jones EA, Szabo G. 2012. IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steato-hepatitis in mice. J Clin Invest. 122:3476–3489.
  • Prabhakar PV, Reddy UA, Singh SP, Balasubramanyam A, Rahman MF, Indu Kumari S, Agawane SB, Murty US, Grover P, Mahboob M. 2012. Oxidative stress induced by aluminum oxide nanomaterials after acute oral treatment in Wistar rats. J Appl Toxicol. 32:436–445.
  • Ravishankar RV, Jamuna BA. 2011. Nanoparticles and their potential application as anti-microbials. In: Méndez-Vilas A, editor. Science against microbial pathogens: Communicating current research and technological advances. Badajoz (Spain): Formatex. p. 197–209.
  • Roy R, Kumar S, Tripathi A, Das M, Dwivedi, PD. 2014. Interactive threats of nanoparticles to the biological system. Immunol Lett. 158:79–87.
  • Saeidnia S, Abdollahi M. 2013. Toxicological and pharmacological concerns on oxidative stress and related diseases. Toxicol Appl Pharmacol. 273:442–455.
  • Shrivastava R, Raza S, Yadav A, Kushwaha P, Flora SJ. 2014. Effects of sub-acute exposure to TiO2, ZnO and Al2O3 nanoparticles on oxidative stress and histological changes in mouse liver and brain. Drug Chem Toxicol. 37:336–347.
  • Shurin MR, Yanamala N, Kisin ER, Tkach AV, Shurin GV, Murry AR, Leonard HD, Reynolds JS, Gutkin DW, Star A, et al. 2014. Graphene oxide attenuates TH2-type immune responses, but augments airway remodeling and hyper-responsiveness in a murine model of asthma. ACS Nano. 8:5585–5599.
  • Staskal DF, Diliberto JJ, De Vito MJ, Birnbaum LS. 2005. Toxicokinetics of BDE 47 in female mice: Effect of dose, route of exposure, and time. Toxicol Sci. 83:215–223.
  • Tavakoli AH, Maram PS, Widgeon SJ, Rufner J, van Benthem K, Ushakov S, Sen S, Navrotsky A. 2013. Amorphous alumina nanoparticles: Structure, surface energy, and thermodynamic phase stability. J Phys Chem. 117:17123–17130.
  • Tkach AV, Yanamala N, Stanley S, Shurin MR, Shurin GV, Kisin ER, Murray AR, Pareso S, Khaliullin T, Kotchey GP, et al. 2013. Graphene oxide, but not fullerenes, targets immunoproteasomes and suppresses antigen presentation by dendritic cells. Small. 9:1686–1690.
  • Vasilevko V, Ghochikyan A, Holterman MJ, Agadjanyan MG. 2002. CD80 (B7-1) and CD86 (B7-2) are functionally equivalent in the initiation and maintenance of CD4+ T-cell proliferation after activation with suboptimal doses of PHA. DNA Cell Biol. 21:137–149.
  • Vereda F, Martin-Molina A, Hidalgo-Alvarez R, Quesada-Pérez, M. 2015. Specific ion effects on the electro-kinetic properties of iron oxide nanoparticles: Experiments and simulations. Phys Chem Chem Phys. 17:17069–17078.
  • Willhite CC, Karyakina NA, Yokel RA, Yenugadhati N, Wisniewski TM, Arnold IM, Momoli F, Krewski D. 2014. Systematic review of potential health risks posed by pharmaceutical, occupational and consumer exposures to metallic and nano-scale aluminum, aluminum oxides, aluminum hydroxide and its soluble salts. Crit Rev Toxicol. 44(Suppl 4):1–80.
  • Zimmemermann HW, Trautwein C, Tacke F. 2012. Functional role of monocytes and macrophages for the inflammatory response in acute liver injury. Front Physiol. 3:56.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.